Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas

PURPOSE: To report the clinicopathological features and mid- to long-term oncologic results of Xp11.2 translocation/transcription factor E3 (TFE3) gene fusion renal cell carcinomas (Xp11.2 translocation RCCs) in a single large-volume centrecentre. METHODS: Clinical and follow-up data of 46 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiale, Zhao, Ling, Yang, Zhaolin, Chen, Yonghui, Wu, Xiaorong, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295427/
https://www.ncbi.nlm.nih.gov/pubmed/35850864
http://dx.doi.org/10.1186/s12894-022-01060-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295427/
https://www.ncbi.nlm.nih.gov/pubmed/35850864
http://dx.doi.org/10.1186/s12894-022-01060-1

Ejemplares similares